Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Trachelogenin

Cat. No.: IBDI-430872

Trachelogenin ((-)-Trachelogenin) is an HCV entry inhibitor without genotype specificity, and with low cytotoxicity. Trachelogenin inhibits HCVcc infection and HCVpp cell entry in a dose-dependent manner with an IC50 of 0.325 and 0.259 μg/mL in HCVcc and HCVpp models, respectively. Trachelogenin exhibits effective antiviral, anti-inflammatory and analgesic effects.

Size (Solid):

Product Details

Target HCV
Molecular Weight 388.41
Appearance Solid
Synonyms (-)-Trachelogenin
SMILES O[[email protected]]1([[email protected]](COC1=O)CC(C=C2)=CC(OC)=C2OC)CC(C=C3)=CC(OC)=C3O
Structure Classification Phenylpropanoids>Lignans
Phenols>Monophenols
Purity 99.56%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.